Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 5,890 shares at $0.98 ($6K) on 2022-06-02, disclosed to the SEC on 2022-06-06.
Open-market purchase of $6k CRVS by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.97 | 170 | $165 | 2.8% |
| 2 | $0.98 | 4,830 | $5K | 81.6% |
| 3 | $1.01 | 890 | $899 | 15.5% |
| Total | $0.98 avg | 5,890 | $6K | 100% |
| Filing → |
| CRVS | BUY | 2022-12-15 | $45K | — | Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |